Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.
about
Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 DiabetesUrine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational studyEffects of a Follow-On Formula Containing Isomaltulose (Palatinose™) on Metabolic Response, Acceptance, Tolerance and Safety in Infants: A Randomized-Controlled TrialA Practical Review of C-Peptide Testing in DiabetesPost-glucose-load urinary C-peptide and glucose concentration obtained during OGTT do not affect oral minimal model-based plasma indicesPractical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis.The clinical utility of C-peptide measurement in the care of patients with diabetesRandom non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors.Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.Tests aiding diagnosis of monogenic diabetes
P2860
Q26747696-B6845E80-F4FD-418E-8CA6-62C484AA0707Q28660810-F7E1B73D-DBEE-4614-87E9-9EBC05C92390Q33467472-560FBB93-BA86-432A-AA2C-42F239D0D5D7Q33732640-0ED8B39E-A561-4BC1-A391-3E50F68C0011Q36778119-DFDF1ACB-B8F7-41EB-8D96-47EEEC712258Q36818151-C06E3E31-41A6-45B8-9584-F353644FFBBAQ37108880-1CDF0797-42E2-4368-A823-295F29A9BB9FQ41251582-29335085-0233-4C72-9510-E8E4CEDF0FE8Q42380027-C3E40E37-1D22-48B1-8F1E-B676E23456EEQ51280338-C28BE638-B4A1-4BF5-9F26-3024A67C2808Q52874770-8454E9B7-FC24-4AA4-9E8D-3C8A7ADE42D2Q54580077-AE910256-4F25-4919-B6B2-B8F68B0CA0B2Q57917247-020308EC-1651-4842-B5ED-1DCF370931E2
P2860
Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Validation of a single-sample ...... patients with Type 2 diabetes.
@en
Validation of a single-sample ...... patients with Type 2 diabetes.
@nl
type
label
Validation of a single-sample ...... patients with Type 2 diabetes.
@en
Validation of a single-sample ...... patients with Type 2 diabetes.
@nl
prefLabel
Validation of a single-sample ...... patients with Type 2 diabetes.
@en
Validation of a single-sample ...... patients with Type 2 diabetes.
@nl
P2093
P2860
P1433
P1476
Validation of a single-sample ...... patients with Type 2 diabetes.
@en
P2093
A T Hattersley
B A Knight
B M Shields
P2860
P356
10.1111/J.1464-5491.2011.03428.X
P577
2012-01-01T00:00:00Z